Conmed

CONMED Corporation is a publicly traded American medical-technology company that develops and manufactures equipment and disposable products used in surgery and patient care. Its principal areas include orthopedic surgery, laparoscopic and general surgery, and systems intended to support clinical procedures and postoperative care. The company’s portfolio spans surgical instruments, visualization and insufflation equipment, smoke-evacuation systems, orthopedic fixation products, implants, and related patient-care technologies. The business began in 1970 in Utica, New York, when Eugene Corasanti acquired a small medical-supplies distributor. The enterprise was initially called Concor Enterprises and was later renamed Consolidated Medical Equipment, Inc. Its first product was a disposable electrocardiogram electrode. From that starting point, CONMED developed through a combination of internal product development and acquisitions, adding capabilities in electrosurgery, endoscopy, orthopedics, sports medicine, and surgical visualization. Acquisitions have been central to the company’s expansion. Over several decades, CONMED acquired or integrated businesses and product lines from companies including Bristol-Myers Squibb, adding Aspen Labs and later Linvatec; Birtcher Corporation, known for the Hyfrecator; ValMed; NorTrex Medical; Core Dynamics; Bionx Implants; an endoscopic business from C. R. Bard; Viking Systems; SurgiQuest; the ExoShape ACL product line from MedShape; Buffalo Filter; In2Bones; and Biorez. These transactions broadened the company’s reach across surgical disciplines and added technologies in minimally invasive surgery, sports medicine, orthopedic implants, and surgical smoke management. CONMED’s named products include the AirSeal iFS insufflator, the PlumeSafe X5 Smoke Evacuator, the BioBrace Reinforced Bioinductive Implant, the Y-Knot All-Suture Anchor, and the Argo Knotless Suture Anchor. These offerings illustrate the company’s emphasis on procedure-enabling equipment and implants rather than consumer healthcare products. The company manufactures hundreds of products and operates manufacturing facilities in the United States and Mexico, alongside international offices and a global commercial footprint. The company’s headquarters moved from Utica, New York, to Largo, Florida, before July 2022. Its stated culture and mission emphasize supporting healthcare professionals and the patients they serve. Leadership continuity has included founder Eugene Corasanti, who remained chief executive until 2006, followed by later leadership under Curt Hartman. Pat Beyer became president and chief executive officer on January 1, 2025. CONMED remains an active medical-device company focused on helping hospitals, surgeons, and other healthcare providers conduct procedures and pursue improved patient outcomes.

CONMED traces its origins to 1970, when Eugene Corasanti purchased a small medical-supplies distributor in Utica, New York. The company initially operated as Concor Enterprises and was subsequently renamed Consolidated Medical Equipment, Inc. Its first product was a disposable ECG electrode, establishing an early focus on products used directly in clinical care rather than on consumer medical goods. The company expanded over time through acquisitions and the addition of new surgical specialties. In 1989, it acquired Aspen Labs from Bristol-Myers Squibb. In 1995, it added New Dimensions in Medicine and Birtcher Corporation, the manufacturer associated with the Hyfrecator. In 1997, it acquired Linvatec from Bristol-Myers Squibb, an important step in building its orthopedic and surgical-device activities. Further transactions in 2002 added ValMed and NorTrex Medical, followed in 2003 by Core Dynamics and Bionx Implants. In 2004, CONMED acquired the endoscopic unit of C. R. Bard, strengthening its position in minimally invasive and endoscopic procedures. The acquisition strategy continued in the following decade. CONMED acquired Viking Systems in 2012, adding to its surgical visualization and minimally invasive technology capabilities. In 2016, it acquired SurgiQuest, whose technologies were associated with laparoscopic surgery and insufflation. In 2017, the company acquired the ExoShape ACL product line from MedShape, extending its sports-medicine and orthopedic reconstruction offering. In 2019, Buffalo Filter became part of CONMED, broadening its presence in surgical smoke evacuation and operating-room safety equipment. The company later acquired In2Bones and Biorez in 2022, adding further orthopedic and extremity-related products and technologies. CONMED’s physical and corporate footprint also changed during this period. The company’s historic base was Utica, New York, but by July 2022 its headquarters had moved to Largo, Florida. It maintains manufacturing facilities in the United States and Mexico, international offices, and a global commercial presence. Its product range grew from the early disposable ECG electrode into a portfolio of hundreds of medical devices and surgical products. The company’s current portfolio includes insufflation equipment such as the AirSeal iFS, surgical smoke-management products such as the PlumeSafe X5 Smoke Evacuator, orthopedic and sports-medicine implants such as the BioBrace Reinforced Bioinductive Implant and the Y-Knot and Argo suture-anchor systems, as well as other equipment for laparoscopic, general, orthopedic, and patient-care applications. These products support procedures performed by hospitals and other healthcare providers. Corasanti served as chief executive until 2006. Curt Hartman later held the combined roles of president, chief executive officer, and chairman of the board from 2014. Pat Beyer became president and chief executive officer on January 1, 2025. Across its history, CONMED has presented itself as a healthcare-partner company whose purpose is to help clinicians deliver care and pursue better patient outcomes. Its development has therefore combined geographic expansion, a broad acquisition program, and continuing specialization in procedure-focused medical technologies.

• 2025

  Pat Beyer becomes chief executive

  [1]CONMED Corporationen.wikipedia.org

  Pat Beyer assumed the roles of president and chief executive officer on January 1, 2025.

• 2022

  In2Bones and Biorez acquisitions

  [1]CONMED Corporationen.wikipedia.org

  CONMED acquired In2Bones and Biorez as part of its continued orthopedic expansion.

• 2022

  Headquarters relocation

  [1]CONMED Corporationen.wikipedia.org

  The company’s headquarters moved from Utica, New York, to Largo, Florida.

• 2019

  Buffalo Filter acquisition

  [1]CONMED Corporationen.wikipedia.org

  The company acquired Buffalo Filter, adding surgical smoke-evacuation products and expertise.

• 2017

  ExoShape ACL product-line acquisition

  [1]CONMED Corporationen.wikipedia.org

  CONMED acquired the ExoShape ACL product line from MedShape.

• 2016

  SurgiQuest acquisition

  [1]CONMED Corporationen.wikipedia.org

  The acquisition of SurgiQuest added laparoscopic-surgery and insufflation-related capabilities.

• 2012

  Viking Systems acquisition

  [1]CONMED Corporationen.wikipedia.org

  CONMED acquired Viking Systems and expanded its surgical visualization capabilities.

• 2004

  C. R. Bard endoscopic unit acquisition

  [1]CONMED Corporationen.wikipedia.org

  CONMED acquired the endoscopic unit of C. R. Bard, strengthening its minimally invasive surgery portfolio.

• 2003

  Core Dynamics and Bionx Implants acquisitions

  [1]CONMED Corporationen.wikipedia.org

  The company acquired Core Dynamics and Bionx Implants.

• 2002

  ValMed and NorTrex Medical acquisitions

  [1]CONMED Corporationen.wikipedia.org

  CONMED added ValMed and NorTrex Medical to its business.

• 1997

  Linvatec acquisition

  [1]CONMED Corporationen.wikipedia.org

  CONMED acquired Linvatec from Bristol-Myers Squibb, expanding its surgical and orthopedic platform.

• 1995

  New Dimensions in Medicine and Birtcher acquisitions

  [1]CONMED Corporationen.wikipedia.org

  The company acquired New Dimensions in Medicine and Birtcher Corporation, associated with the Hyfrecator product.

• 1989

  Aspen Labs acquisition

  [1]CONMED Corporationen.wikipedia.org

  CONMED acquired Aspen Labs from Bristol-Myers Squibb.

• 1970

  Company founded in Utica

  [1]CONMED Corporationen.wikipedia.org

  Eugene Corasanti purchased a small medical-supplies distributor, initially called Concor Enterprises, and began building the business that later became CONMED.

A procedure-focused medical-device manufacturer supplying hospitals and healthcare professionals with equipment, disposable products, surgical technologies, and orthopedic implants, with particular strength in orthopedic, minimally invasive, laparoscopic, general-surgery, and patient-care applications.

• Laparoscopic insufflation system

  AirSeal iFS

  The AirSeal iFS is a named CONMED insufflation product for laparoscopic surgery. It represents the company’s focus on procedure-enabling operating-room equipment used alongside minimally invasive surgical techniques.

• Surgical smoke evacuation

  PlumeSafe X5 Smoke Evacuator

  The PlumeSafe X5 is a surgical smoke-evacuation system associated with CONMED’s operating-room safety and patient-care portfolio. It is intended to support the management of smoke generated during surgical procedures.

• Orthopedic implant

  BioBrace Reinforced Bioinductive Implant

  BioBrace is a reinforced bioinductive implant in CONMED’s orthopedic and sports-medicine portfolio. It illustrates the company’s expansion beyond instruments into implantable products used in musculoskeletal procedures.

• Orthopedic suture anchor

  Y-Knot All-Suture Anchor

  The Y-Knot is an all-suture anchor used in orthopedic and sports-medicine procedures. It belongs to CONMED’s family of fixation products for soft-tissue repair.

• Orthopedic suture anchor

  Argo Knotless Suture Anchor

  The Argo Knotless is a knotless suture anchor in CONMED’s orthopedic product portfolio. It is designed for use in surgical soft-tissue fixation and reflects the company’s sports-medicine focus.

• Electrosurgical equipment

  Hyfrecator

  The Hyfrecator is an electrosurgical product associated with Birtcher Corporation, which CONMED acquired in 1995. Its inclusion reflects CONMED’s long-standing presence in electrosurgical equipment.

• 2025

  Chief executive transitionStrategy

  Background

  CONMED entered a new leadership phase after a period of expansion across surgical and orthopedic devices.

  Action taken

  Pat Beyer became president and chief executive officer on January 1, 2025.

  Aftermath

  Beyer became the company’s current chief executive, while the company continued its focus on healthcare-provider and patient outcomes.

  Source

• 2022

  Acquisition of In2Bones and BiorezM&A

  Background

  CONMED continued to invest in orthopedic and extremity-related medical technologies.

  Action taken

  The company acquired In2Bones and Biorez.

  Aftermath

  The acquisitions expanded its orthopedic implant and related product capabilities.

  Source

• 2019

  Acquisition of Buffalo FilterM&A

  Background

  Surgical smoke management was an adjacent operating-room technology category.

  Action taken

  CONMED acquired Buffalo Filter.

  Aftermath

  The transaction broadened CONMED’s surgical smoke-evacuation capabilities.

  Source

• 2017

  Acquisition of the ExoShape ACL product lineM&A

  Background

  CONMED was extending its sports-medicine and orthopedic reconstruction activities.

  Action taken

  It acquired the ExoShape ACL product line from MedShape.

  Aftermath

  The product line added to CONMED’s orthopedic and sports-medicine offering.

  Source

• 2016

  Acquisition of SurgiQuestM&A

  Background

  CONMED was expanding in laparoscopic surgery and related operating-room technologies.

  Action taken

  The company acquired SurgiQuest.

  Aftermath

  The acquisition contributed to CONMED’s insufflation and laparoscopic-surgery portfolio.

  Source

• 2012

  Acquisition of Viking SystemsM&A

  Background

  Surgical visualization was an area of continuing technology development.

  Action taken

  CONMED acquired Viking Systems.

  Aftermath

  The transaction added to the company’s visualization and minimally invasive surgery capabilities.

  Source

• 2004

  Acquisition of C. R. Bard’s endoscopic unitM&A

  Background

  CONMED sought greater participation in endoscopic and minimally invasive procedures.

  Action taken

  The company acquired the endoscopic unit of C. R. Bard.

  Aftermath

  The acquisition reinforced CONMED’s endoscopic and minimally invasive surgery offering.

  Source

• 2003

  Acquisition of Core Dynamics and Bionx ImplantsM&A

  Background

  The company continued adding specialized medical-device businesses.

  Action taken

  CONMED acquired Core Dynamics and Bionx Implants.

  Aftermath

  The transactions expanded the company’s technology and implant-related capabilities.

  Source

• 2002

  Acquisition of ValMed and NorTrex MedicalM&A

  Background

  CONMED used acquisitions to broaden its product and technology base.

  Action taken

  The company acquired ValMed and NorTrex Medical.

  Aftermath

  Both businesses became part of the company’s expanding surgical-device portfolio.

  Source

• 1997

  Acquisition of LinvatecM&A

  Background

  CONMED continued to build scale in surgical and orthopedic devices.

  Action taken

  It acquired Linvatec from Bristol-Myers Squibb.

  Aftermath

  The deal strengthened the company’s orthopedic and surgical-device activities.

  Source

Showing the 10 most recent.

1. 1CONMED Corporationen.wikipedia.org